Clinical Trials Directory

Trials / Completed

CompletedNCT02765035

C-Leg 3 and C-Leg 4 Study in Transfemoral Amputees

A Randomized, Blinded, Cross-over Trial to Evaluate the Safety, Functional Mobility and Satisfaction of the Microprocessor Controlled Prosthetic Knee Component C-Leg 4 in Transfemoral Amputees

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
18 (actual)
Sponsor
Otto Bock Healthcare Products GmbH · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The aim of this post-market study is to confirm that the microprocessor controlled prosthetic knee components (C-Leg 3 and C-Leg 4) in comparison to mechanical knee joints can bring additional benefit to the users primarily on level walking and secondarily in safety, stair and hill mobility, activities of daily living, satisfaction and preference.

Detailed description

During the last two decades many microprocessor controlled knee joints (MPK) appeared on the market.The newly developed C-Leg 4 aims to provide improved standing function while in the same time offering technology of knee´s previous version (C-Leg 3). Since added functional benefit of a knee joint cannot be anticipated just due to the fact that the knee is controlled by the microprocessor, the aim of this post-market study is to evaluate the safety, functional mobility and satisfaction of the microprocessor controlled prosthetic knee components C-Leg 3 and C-Leg 4 in comparison to mechanical knee joints. Additional goal is to improve the methodological quality of research conducted in the field.

Conditions

Interventions

TypeNameDescription
DEVICEC-Leg 4Microprocessor Controlled Knee
DEVICEC-Leg 3Microprocessor Controlled Knee

Timeline

Start date
2016-04-01
Primary completion
2018-05-30
Completion
2018-05-30
First posted
2016-05-06
Last updated
2021-10-14
Results posted
2021-10-14

Locations

2 sites across 2 countries: Austria, Belgium

Source: ClinicalTrials.gov record NCT02765035. Inclusion in this directory is not an endorsement.